Specifically, C9 protein levels in MS cases were estimated, using LMM, on average 0.53 HC SD higher as compared to healthy control (95% CI: 0.25, 0.81) with a corrected p-value < 0.012. The gene discussed is C9; the disease is myeloid sarcoma.